| Members |
associationTargetComponent |
| pT1a: Tumour 5 cm or less in greatest dimension, superficial tumour (extraosseous primitive neuroectodermal tumour/Ewing's sarcoma) |
pT1a |
| pT1a: Tumour 5 cm or less in greatest dimension, superficial tumour (soft tissue) |
pT1a |
| pT1a: Tumour invades lamina propria (oesophagus) |
pT1a |
| pT1a: Tumour invades lamina propria (gallbladder) |
pT1a |
| pT1a: Tumour invades lamina propria (stomach) |
pT1a |
| pT1a: Tumour involves ipsilateral parietal (mediastinal, diaphragmatic) pleura. No involvement of the visceral pleura (thoracic mesothelioma) |
pT1a |
| pT1a: Tumor limited to one vocal cord (may involve anterior or posterior commissure) with normal mobility (larynx, glottis) |
pT1a |
| pT1a: Tumour limited to the iris (not more than 3 clock hours in size) (iris) (uveal melanoma) |
pT1a |
| pT1a: Tumour more than 0.1 cm but not more than 0.5 cm in greatest dimension (breast) |
pT1a |
| pT1b (IB): Clinically visible lesion confined to the cervix or microscopic lesion greater than T1a2/IA2 (TNM category and FIGO stage) (uterine cervix) |
pT1b |
| pT1b (IB): Tumour confined to the vulva or vulva and perineum, 2 cm or less in greatest dimension, and with stromal invasion greater than 1 mm (TNM category and FIGO stage) (vulva) |
pT1b |
| pT1b (IB): Tumour invades less than one-half of the myometrium (TNM category and FIGO stage) (corpus uteri) |
pT1b |
| pT1b (IB): Tumor limited to both ovaries; capsule intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) |
pT1b |
| pT1b (IB): Tumour limited to both tubes, without penetrating the serosal surface; no ascites (TNM category and FIGO stage) (fallopian tube) |
pT1b |
| pT1b category |
pT1b |
| pT1b1 (IB1): Clinically visible lesion 4.0 cm or less in greatest dimension (TNM category and FIGO stage) (uterine cervix) |
pT1b1 |
| pT1b1 category |
pT1b1 |
| pT1b2 (IB2): Clinically visible lesion more than 4.0 cm in greatest dimension (TNM category and FIGO stage) (uterine cervix) |
pT1b2 |
| pT1b2 category |
pT1b2 |
| pT1b: Melanoma 1.0 mm or less in thickness and level IV or V or with ulceration (melanoma of the skin) |
pT1b |
| pT1b: Tumour 10 mm or less in greatest diameter and 2.5 mm or less in greatest height (thickness) with microscopic extraocular extension (ciliary body and choroid) (uveal melanoma) |
pT1b |
| pT1b: Tumour 2 cm or less in greatest dimension, limited to dermis and greater than 2 mm in thickness, but not more than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
pT1b |
| pT1b: Tumour 5 cm or less in greatest dimension, deep tumour (extraosseous primitive neuroectodermal tumour/Ewing's sarcoma) |
pT1b |
| pT1b: Tumour 5 cm or less in greatest dimension, deep tumour (soft tissue) |
pT1b |
| pT1b: Tumour invades muscle layer (gallbladder) |
pT1b |
| pT1b: Tumour invades submucosa (oesophagus) |
pT1b |
| pT1b: Tumour invades submucosa (stomach) |
pT1b |
| pT1b: Tumour involves both vocal cords (may involve anterior or posterior commissure) with normal mobility (larynx, glottis) |
pT1b |
| pT1b: Tumour involves ipsilateral parietal (mediastinal, diaphragmatic) pleura, with focal involvement of the visceral pleura (thoracic mesothelioma) |
pT1b |
| pT1b: Tumour limited to the iris (more than 3 clock hours in size) (iris) (uveal melanoma) |
pT1b |
| pT1b: Tumor more than 0.5 cm but not more than 1 cm in greatest dimension (breast) |
pT1b |
| pT1b: Tumour more than 4 cm but not more than 7 cm in greatest dimension, limited to the kidney (kidney) |
pT1b |
| pT1b:Tumor >0.5 cm but <= 1 cm in greatest dimension (breast) |
pT1b |
| pT1c (IC): Tumour invades one-half or more of the myometrium (TNM category and FIGO stage) (corpus uteri) |
pT1c |
| pT1c (IC): Tumour limited to one or both ovaries with any of the following: capsule ruptured, tumour on ovarian surface, malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) |
pT1c |
| pT1c (IC): Tumour limited to one or both tubes with extension onto or through the tubal serosa, or with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (fallopian tube) |
pT1c |
| pT1c category |
pT1c |
| pT1c: Tumour 10 mm or less in greatest diameter and 2.5 mm or less in greatest height (thickness) with macroscopic extraocular extension (ciliary body and choroid) (uveal melanoma) |
pT1c |
| pT1c: Tumour 2 cm or less in greatest dimension, invading the subcutis and/or greater than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
pT1c |
| pT1c: Tumour limited to the iris with melanomalytic glaucoma (iris) (uveal melanoma) |
pT1c |
| pT1c: Tumour more than 1 cm but not more than 2 cm in greatest dimension (breast) |
pT1c |
| pT1mic category |
pT1mi |
| pT1mic: Microinvasion 0.1 cm or less in greatest dimension (breast) |
pT1mi |
| pT2 (II): Cervical carcinoma invades beyond uterus but not to pelvic wall or to lower third of vagina (TNM category and FIGO stage) (uterine cervix) |
pT2 |
| pT2 (II): Tumour confined to the vulva or vulva and perineum, more than 2 cm in greatest dimension (TNM category and FIGO stage) (vulva) |
pT2 |
| pT2 (II): Tumour extends outside of uterus but limited to genital structures (ovary, tube, vagina, broad ligaments) (TNM category and FIGO stage) (gestational trophoblast) |
pT2 |
| pT2 (II): Tumour invades cervix but does not extend beyond uterus (TNM category and FIGO stage) (corpus uteri) |
pT2 |
| pT2 (II): Tumour invades paravaginal tissues but not to pelvic wall (TNM category and FIGO stage) (vagina) |
pT2 |
| pT2 (II): Tumour involves one or both fallopian tubes with pelvic extension (TNM category and FIGO stage) (fallopian tube) |
pT2 |
| pT2 (II): Tumour involves one or both ovaries with pelvic extension AND/OR implants (TNM category and FIGO stage) (ovary) |
pT2 |
| pT2 category |
pT2 |
| pT2: Melanoma 1.01 to 2.0 mm in thickness, with or without ulceration (melanoma of the skin) |
pT2 |
| pT2: Minimal invasion of the optic nerve and/or optic coats (retinoblastoma) |
pT2 |
| pT2: Organ confined (prostate) |
pT2 |
| pT2: Solitary tumour with vascular invasion or multiple tumours none more than 5 cm (liver, including intrahepatic bile ducts) |
pT2 |
| pT2: Tumor causing bone erosion or destruction including extension into the hard palate and/or middle nasal meatus, except extension to posterior wall of maxillary sinus and pterygoid plates (maxillary sinus) |
pT2 |
| pT2: Tumour confluent with or extending into the ciliary body and/or choroid (iris) (uveal melanoma) |
pT2 |
| pT2: Tumour extends to the soft tissues (nasopharynx) |
pT2 |
| pT2: Tumour extends to the supraglottis AND/OR subglottis, AND/OR with impaired vocal cord mobility (larynx, glottis) |
pT2 |
| pT2: Tumour extends to vocal cord(s) with normal or impaired mobility (larynx, subglottis) |
pT2 |
| pT2: Tumor greater than 10 mm but not more than 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) (ciliary body and choroid) (uveal melanoma) |
pT2 |
| pT2: Tumour invades beyond the wall of bile duct (extrahepatic bile ducts) |
pT2 |
| pT2: Tumour invades duodenal wall (ampulla of Vater) |
pT2 |
| pT2: Tumour invades more than one subsite of hypopharynx or an adjacent site, or measures more than 2 cm but not more than 4 cm in greatest diameter without fixation of hemilarynx (hypopharynx) |
pT2 |
| pT2: Tumour invades mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (e.g., mucosa of base of tongue, vallecula, medial wall of pyriform sinus) without fixation of the larynx |
pT2 |
| pT2: Tumour invades muscularis (renal pelvis and ureter) |
pT2 |
| pT2: Tumour invades muscularis propria (appendix) |
pT2 |
| pT2: Tumour invades muscularis propria (colon/rectum) |
pT2 |
| pT2: Tumour invades muscularis propria (oesophagus) |
pT2 |
| pT2: Tumour invades muscularis propria (small intestine) |
pT2 |
| pT2: Tumour invades muscularis propria (urinary bladder, ureter, renal pelvis) |
pT2 |
| pT2: Tumor invades muscularis propria or subserosa (stomach) |
pT2 |
| pT2: Tumour invades perimuscular connective tissue; no extension beyond serosa or into liver (gallbladder) |
pT2 |
| pT2: Tumour invading two subsites in a single region or extending to involve an adjacent region within the nasoethmoidal complex, with or without bony invasion (nasal cavity and ethmoid sinus) |
pT2 |
| pT2: Tumour involves any of the ipsilateral pleural surfaces with at least one of the following: confluent visceral pleural tumour (including fissure), invasion of diaphragmatic muscle, invasion of lung parenchyma (thoracic mesothelioma) |
pT2 |
| pT2: Tumour limited to the pancreas, more than 2 cm in greatest dimension (exocrine pancreas) |
pT2 |
| pT2: Tumour limited to the testis and epididymis with vascular/lymphatic invasion, or tumour extending through the tunica albuginea with involvement of the tunica vaginalis (testis) |
pT2 |
| pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension (lip and oral cavity) |
pT2 |
| pT2: Tumour more than 2 cm but not more than 4 cm in greatest dimension (oropharynx) |
pT2 |
| pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension limited to the thyroid (thyroid) |
pT2 |
| pT2: Tumour more than 2 cm but not more than 4 cm in greatest dimension without extraparenchymal extension (major salivary glands) |
pT2 |
| pT2: Tumour more than 2 cm but not more than 5 cm in greatest dimension (anal canal) |
pT2 |
| pT2: Tumour more than 2 cm but not more than 5 cm in greatest dimension (breast) |
pT2 |
| pT2: Tumour more than 2 cm, but not more than 5 cm, in greatest dimension (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
pT2 |
| pT2: Tumour more than 5 cm in greatest dimension (extraosseous primitive neuroectodermal tumour/Ewing's sarcoma) |
pT2 |
| pT2: Tumour more than 7 cm in greatest dimension, limited to the kidney (kidney) |
pT2 |
| pT2: Tumour more than 8 cm in greatest dimension (bone) |
pT2 |
| pT2: Tumour more than 8 cm in greatest dimension (osseous primitive neuroectodermal tumour/Ewing's sarcoma) |
pT2 |
| pT2: Tumour of lung as per AJCC 6th Edition definition (lung) |
pT2 |
| pT2a (IIA): Extension to AND/OR implants on uterus AND/OR tube(s). No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) |
pT2a |
| pT2a (IIA): Tumour involves one or both fallopian tubes with extension and/or metastasis to the uterus and/or ovaries (TNM category and FIGO stage) (fallopian tube) |
pT2a |
| pT2a (IIA): Tumour limited to the glandular epithelium of the endocervix. There is no evidence of connective tissue stromal invasion (TNM category and FIGO stage) (corpus uteri) |
pT2a |
| pT2a (IIA): Tumor without parametrial invasion (TNM category and FIGO stage) (uterine cervix) |
pT2a |
| pT2a category |
pT2a |
| pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration (melanoma of the skin) |
pT2a |
| pT2a: Tumour 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) without microscopic extraocular extension (ciliary body and choroid) (uveal melanoma) |
pT2a |
| pT2a: Tumour confluent with or extending into the ciliary body and/or choroid with melanomalytic glaucoma (iris) (uveal melanoma) |
pT2a |
| pT2a: Tumour extends to the soft tissues of the oropharnyx and/or nasal cavity without parapharyngeal extension (nasopharynx) |
pT2a |
| pT2a: Tumour invades muscularis propria (stomach) |
pT2a |
| pT2a: Tumour invades optic nerve up to, but not through, the level of the lamina cribrosa (retinoblastoma) |
pT2a |
| pT2a: Tumour invades superficial muscle (inner half) (urinary bladder) |
pT2a |
FHIR